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Abstract We examined the impact on depression at
6 months postpartum of maternal supplementation with
small-quantity lipid-based nutrient supplement (SQ-LNS)
compared to supplementation with iron and folic acid
(IFA) or multiple micronutrients (MMN). In this partially
double-blinded randomized controlled trial, pregnant
women ≤20 weeks gestation (n = 1320) were recruited
from antenatal clinics and randomly assigned to receive
either (1) SQ-LNS during pregnancy and for 6 months
postpartum, or (2) IFA during pregnancy only, or (3)
MMN during pregnancy and for 6 months postpartum.
Maternal depressive symptoms were measured at 6 months
postpartum using the Edinburgh Postnatal Depression
Scale (EPDS). Women who scored 12 or more on the
EPDS were considered to show symptoms of depression.
One thousand one hundred fifty-one women were included
in this analysis (LNS = 382, IFA = 387 and MMN = 382).
Characteristics of the three groups were similar at baseline,
and there were no significant differences between women
who were included in the analysis (n = 1151) and those
who were not (n = 169). At 6 months postpartum, 13% of
the women overall showed symptoms of depression, and
this did not differ by group (LNS = 13.1%, IFA = 11.2%
and MMN = 14.7%. P = 0.36). The median (25, 75 per-
centile) EPDS score did not differ by group (LNS 4.0 (1.0,
8 .0 ) , IFA 4 .0 (1 .0 , 8 .0 ) , MMN 5.0 (2 .0 , 9 .0 ) ,
Ptransformed = 0.13). Adjustment for covariates did not alter
these findings. Maternal supplementation with SQ-LNS
compared to MMN or IFA did not affect postnatal depres-
sive symptoms in this sample of Ghanaian women.
Keywords Lipid-based nutrient supplements . Postpartum
depression . Ghana
Introduction
Globally, postpartum depression (PPD) has been reported to
affect 10–20% of women (Fisher et al. 2012; Nhiwatiwa et al.
1998; O’Hara and Swain 1996; Stewart et al. 2016; Uwakwe
2003). In one study in the Eastern region of Ghana, 9.3% of
the women were reported to show symptoms of depression at
6 months postpartum (Okronipa et al. 2012). Over the years,
PPD has received attention because of the deleterious effect it
may have on both maternal and child health. For example,
several studies have reported associations between PPD and
increased infant diarrhoeal episodes (Okronipa et al. 2012;
Rahman et al. 2007), poor mother-child interactions (Murray
et al. 1996) and sub-optimal breastfeeding practices
(Henderson et al. 2003).
Inadequate nutrition may play a role in mental health,
including depression. Links between nutrient deficiencies
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calcium, iron, selenium, zinc and omega-3 fatty acids
(Bodnar and Wisner 2005; Leung and Kaplan 2009).
Results of randomized controlled trials that have exam-
ined nutrient supplementation and PPD have however
been mixed. In Guatemala, weekly vs daily supplementa-
tion with multiple micronutrients (MMN) for 12 weeks
resulted in improved depression scores among women of
reproduct ive age (Nguyen et al . 2009) . Among
Bangladeshi pregnant women, supplementation with
MMN compared to 30 mg iron from 14 weeks gestation
to 12 weeks postpartum resulted in lower depression
scores (Frith et al. 2009). In Indonesia, however, MMN
supplementation from pregnancy to 3 months postpartum
had no significant effect on maternal ‘mood’ compared to
provision of iron and folic acid (IFA) (Prado et al. 2012).
In South Africa, supplementation during lactation with
iron (compared to placebo) improved depression among
anaemic but not among non-anaemic women (Beard et al.
2005).
Omega-3 fatty acids are another group of nutrients that
have received attention because of their potential role in
the treatment of depression. Studies in animals have sug-
gested that omega-3 fatty acids can affect brain processes
such as those that control mood and anxiety (Carlezon
et al. 2005; Delion et al. 1996). However, research in
humans on the association between omega-3 fatty acid
supplementation and depression has yielded inconsistent
results. A meta-analysis of eight trials conducted in pa-
tients with depressive symptoms reported a significant
clinical benefit of n-3 fatty acid treatment compared to
placebo (Grosso et al. 2014). However, another meta-
analysis of 12 randomized controlled trials found little
evidence to support the use of omega-3 PUFAs to im-
prove depressed mood (Appleton et al. 2006).
Small-quantity lipid-based nutrient supplements (SQ-
LNS) were designed to enrich the diets of target
groups at high risk of malnutrition (Arimond et al.
2013). They are usually made with vegetable oil,
g r o u n d n u t p a s t e , m i l k p ow d e r , s u g a r a n d
micronutrients and provide energy, micro- and macro-
nutrients as well as essential fatty acids. We conducted
a trial to examine the efficacy of SQ-LNS provided to
women during pregnancy and the first 6 months post-
partum, and to their offspring from 6 to 18 months of
age, on pregnancy outcomes and on child growth at
18 months. As a secondary objective, we sought to
examine the impact of fortification of maternal diet
with SQ-LNS compared to supplementation with IFA
and MMN on maternal PPD. We hypothesized that
women who received SQ-LNS during pregnancy would
have lower mean Edinburgh Postnatal Depression Scale
(EPDS) scores at 6 months postpartum compared to
women who received either IFA or MMN.
Methods
Study site, design and arms
The International Lipid-Based Nutrient Supplements trial
in Ghana (iLiNS-DYAD) was conducted from November
2009 to March 2014 in the lower Manya and Yilo Krobo
districts in the Eastern region of Ghana. The area is semi-
urban, and is about 70 km from the national capital,
Accra. Details of the study design have been described
elsewhere (Adu-Afarwuah et al. 2015). Briefly, women
were randomly assigned to receive one of the following
treatments: (a) daily iron (60 mg) and folic acid (400 μg)
capsule during pregnancy, and calcium (Ca) only (akin to
a placebo) during the first 6 months postpartum (IFA
group); (b) daily multiple micronutrient capsule (1–2
RDAs of 18 vitamins and minerals including 20 mg iron)
during pregnancy and the first 6 months postpartum
(MMN group); and (c) daily 20 g SQ-LNS during preg-
nancy and the first 6 months postpartum (LNS group).
The 20 g SQ-LNS contained similar vitamin and mineral
content as the MMN capsule, plus another four minerals
(Ca, P, K, Mg) and essential fatty acids (4.59 g linoleic
acid, 0.59 g α-linolenic acid), and provided 118 kcal en-
ergy (Table 1). Details of how participants were randomly
assigned to the treatment groups have been described
elsewhere (Adu-Afarwuah et al. 2015, 2016). The IFA/
MMN were provided as capsules in a blister pack whereas
the SQ-LNS supplement was in a 20-g sachet.
In a previous paper, we reported a temporary mislabeling of
IFA and MMN capsules (Adu-Afarwuah et al. 2015, 2016).
Briefly, some women (n = 170) who had been initially
assigned to the IFA group received the MMN capsule either
throughout pregnancy (n = 85) or during part of pregnancy
(n = 85), before receiving the intended IFA capsule the rest of
follow-up, and another 170 women initially assigned to the
MMN group also received the IFA capsule either throughout
pregnancy (n = 78) or during part of pregnancy (n = 92), be-
fore receiving the intendedMMN capsule.Women in the LNS
group received the correct supplement throughout the study.
In this current analysis, we included all of the women en-
rolled into the study without discarding any data from those
who received the unintended supplements, since the unintend-
ed exposure occurred only in the pre-natal period. As previ-
ously reported, women in the IFA and MMN groups were
exposed to the unintended supplement for only 13% of the
follow-up days (Adu-Afarwuah et al. 2016). Our main analy-
sis was based on the supplement women were intended to
receive when they were enrolled. In order to address the pro-
tocol violation associated with the consumption of mislabeled
capsules by some of the women during pregnancy, we con-
ducted two sensitivity analyses; the first examined data based
on the supplement that women actually received when they
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were enrolled, and the second examined data only for women
who received supplements after the mislabeling of IFA and
MMN supplements had been corrected.
Recruitment and follow-up
A detailed account of the recruitment process has been given
elsewhere (Adu-Afarwuah et al. 2015). Briefly, pregnant
women were recruited from the antenatal clinics of two hos-
pitals, one polyclinic and one health center in the study area.
Women were considered eligible for the study if they were (1)
pregnant, (2) 18 years or older, (3) 20 gestational weeks or less
and (4) had an antenatal card complete with history and ex-
amination. Women were excluded from the study if they (1)
reported milk or peanut allergy, (2) lived outside the study
area, (3) intended to move out of the study area within the
next 2 years, (4) were unwilling to receive field workers in
their homes or take study supplements, (5) were participating
in another clinical trial or (6) their antenatal card indicated that
they had HIV infection, asthma, epilepsy, tuberculosis or any
malignancy. Eligible women were followed up through
6 months postpartum. Supplements were delivered to women
bi-weekly during pregnancy and lactation, and information on
supplement intake and other data were also collected bi-week-
ly. The depression questionnaire was administered at 6months
postpartum during a scheduled home visit.
Outcome variables
Maternal report of depressive symptoms was assessed at
6 months postpartum using the EPDS (Cox et al. 1987). The
questionnaire was read aloud to the participant in their own
language, and as much as possible, the interviewwas conduct-
ed in private, with only the field worker and participant pres-
ent. The EPDS is a 10-item scale that documents depressive
symptoms that occurred over the past 7 days. Each item was
scored on a four-point rating scale that represented the level of
occurrence (zero the lowest level of occurrence, three the
highest level of occurrence). The scores for all 10 items were
then summed up to obtain a total depression score. Women
with a total EPDS score of 12 and above were classified as
showing symptoms of PPD whereas women who scored be-
low 12 were classified as not showing symptoms of PPD
(Chibanda et al. 2010; Lawrie et al. 1998). This questionnaire
has previously been used in Ghana (Okronipa et al. 2012) and
other African countries (Nhiwatiwa et al. 1998; Stewart et al.
2016; Uwakwe 2003) to measure symptoms of PPD.
Other variables
We collected other data on maternal and household baseline
variables including maternal years of formal education, age,
body mass index (BMI, kg/m2), marital status, anaemia,
gestational age, primiparity, household asset index, household
food insecurity index, housing index and season when depres-
sion data were collected (wet/dry).
Statistical analysis
The statistical analysis plan was posted on our website (www.
ilins.org) before any analysis was initiated. The primary
outcome was maternal total depression score at 6 months
postpartum. We also examined the proportion of women
who scored ≥12 on the EPDS. All analysis was carried out
using SAS for Windows Version 9.4 (SAS Institute, CARY,
NC, USA) and was by intention to treat. All participants who
had missing data for the outcome variable were excluded from
all analysis. Descriptive data are presented as means and
standard deviations or frequencies and percentages. Analysis
of variance and chi-squared testing were used to compare
baseline variables between the three intervention groups.
Adherence to supplement intake during pregnancy and lacta-
tion was calculated as the percentage of pregnancy days after
enrolment to delivery and from delivery to 6 months postpar-
tum, respectively, when supplements were reportedly
consumed.
The difference in the depression scores between the three
groups was analysed using ANCOVA, with Tukey adjustment
for pairwise comparisons. Due to the non-normal distribution
of the depression scores, we square-root transformed the var-
iable before use in analysis. The proportion of women who
scored ≥12 on the EPDS was compared between the three
intervention groups using logistic regression.
We calculated unadjustedmeans (SD) or group percentages
and then repeated the analyses with adjustments for pre-
specified covariates. Covariates we examined included mater-
nal years of formal education, height, age, BMI, marital status,
anaemia at enrolment, gestational age at enrolment,
primiparity, household asset index, household food insecurity
index and season when depression data were collected. Only
covariates significantly associated with the outcome at 10%
level of significance in bivariate analysis were included in the
final adjusted model. A P value was considered to be signif-
icant if α <0.05 (unless otherwise stated). We estimated
pairwise intervention group differences in means and relative
risk for continuous and binary outcomes, respectively.
As per our analysis plan, we examined potential interac-
tions between the intervention group and the variables that
could modify the impact of the intervention on depression
outcomes. The pre-specified baseline variables include mater-
nal years of formal education, height, age, BMI, marital status,
anaemia at enrolment, gestational age at enrolment,
primiparity, household asset index, household food insecurity
index and season at depression data collection.When an effect
modifier was statistically significant (P < 0.1), we performed a
stratified analysis by assessing the adjusted group effect at
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different levels of the effect modifier. For a continuous effect
modifier, the group effect was compared at the tenth percen-
tile, the median and the 90th percentile for continuous out-
comes and for a categorical effect modifier, the group effect
was compared for all levels of the effect modifier.
Ethics
Ethical approval for the study was obtained from the institu-
tional review boards of the University of California, Davis;
Ghana Health Service and University of Ghana Noguchi
Memorial Institute for Medical Research (NMIMR).
Results
Participants
Data were collected between December 2009 and August
2012. Out of 2607 women who were screened at the antenatal
visits, 1926 were eligible to be recruited. Of this number, 1575
were recruited (signed consent form) and 1320 enrolled (par-
ticipated in baseline assessment and randomized to one of the
three study groups) (Fig. 1). Of the 1320 enrolled, depression
data were available for 87% (LNS = 87%, MMN = 87%,
IFA = 88%) and these women were included in this analysis.
There were no statistically significant differences in baseline
characteristics between participants who were included in this
analysis and those who were excluded. The baseline charac-
teristics of women included in the study are shown in Table 2.
On average, women were in their mid-twenties, were about
159 cm tall, had about 7 years of formal education and had
gestational age of 16 weeks. Almost all women reported being
married or cohabiting with a partner. There were no significant
differences in baseline characteristics between the three inter-
vention groups within this analytical sample. Reported adher-
ence (percentage of days supplements was reportedly con-
sumed) to supplement intake in women was lower in the
LNS compared to the IFA and MMN groups during pregnan-
cy (72.5% ± 21.5 vs 77.4% ± 16.9 vs 76.7% ± 17.2%, respec-
tively, P < 0.001) and postpartum (70.0% ± 24.6 vs
77.3% ± 19.6 vs 74.7% ± 21.6%, respectively, P < 0.001).
As previously reported (Adu-Afarwuah et al. 2015, 2016), we
found no significant differences in reported severe adverse
events between groups.
Main group comparisons
Tables 3 and 4 present the unadjusted and adjusted results for
continuous and binary outcomes, respectively, by the inter-
vention group. The reported depression scores at 6 months
postpartum did not differ significantly between the three in-
tervention groups (Table 3). Similarly, when we examined the
proportion of women who scored ≥12 on the EPDS, we found
no significant differences between LNS, IFA and MMN
groups (Table 4). Adjustment for covariates did not alter these
findings.
Effect modification
We examined 11 pre-specified potential effect modifiers, and
3 interactions were significant (P < 0.1): season when depres-
sion data were collected (P = 0.034), housing index
(P = 0.053) and child sex (P = 0.099). Among women
interviewed during the dry season, those in the LNS group
had lower EPDS scores compared to those in the IFA and
MMN groups (1.73 vs 1.95 vs 2.08, P = 0.015). By contrast,
there were no significant differences between LNS, IFA and
MMN groups among women who were interviewed during
the wet season (2.07 vs 1.91 vs 2.03, P = 0.36). Among wom-
en who delivered female infants, there was a trend for those in
the LNS group to have lower EPDS scores compared to those
in the IFA and MMN groups (1.83 vs 2.01 vs 2.13, P = 0.05),
but there were no significant differences among women who
delivered male infants. Among women who had higher (90th
percentile) housing index, those in the IFA group had lower
scores compared to the MMN group (P = 0.013) but not com-
pared to the LNS group; none of the group differences was
significant among women who had a lower housing index.
Sensitivity analysis
In order to address the protocol violation associated with the
consumption of mislabeled capsules by some of the women
during pregnancy as described in the methods section above,
we conducted two sensitivity analyses that examined data (1)
based on the supplement that women actually received when
they were enrolled and (2) only for women who received
supplements after the mislabeling of IFA and MMN supple-
ments had been corrected.
When we examined the data based on the supplement that
women actually received when they were enrolled, we found
that, overall, the IFA group recorded the highest depression
score compared to LNS and MMN groups in both unadjusted
(2.10 vs 1.91 vs 1.90, P = 0.039) and adjusted (2.09 vs 1.89 vs
1.91, P = 0.032) analysis. In the pairwise comparisons, the
IFA group tended to report higher scores compared to the
MMN (unadjusted: P = 0.07; adjusted: P = 0.05) and LNS
(unadjusted: P = 0.06; adjusted: P = 0.07). Depression scores
were not significantly different between the MMN and LNS
groups in adjusted and unadjusted analysis. The proportion of
women who scored ≥12 on the EPDS did not differ signifi-
cantly between the 3 intervention groups in either adjusted or
unadjusted analysis.
In the analysis restricted to women who received supple-
ments after the mislabeling of IFA and MMN supplements
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had been corrected, we found no significant differences be-
tween groups in reported depression scores at 6 months post-
partum in either unadjusted or adjusted analysis, or in the
proportion of women who scored ≥12 on the EPDS (data
not shown).
Discussion
In this semi-urban area of Ghana where the iLiNS study was
conducted, provision of SQ-LNS did not alleviate depressive
symptoms at 6 months postpartum. The findings do not sup-
port our hypothesis that women who received SQ-LNS during
pregnancy would have lower mean EPDS scores at 6 months
postpartum compared to women who received either IFA or
MMN.
In terms of prevalence of PPD, our results are similar to
what was reported in another study in the same study area
(9.3%) where our study was conducted (Okronipa et al.
2012). Studies conducted in other African countries have also
reported similar rates (11–16%) of PPD (Nhiwatiwa et al.
1998; Stewart et al. 2016; Uwakwe 2003).
Our finding of no impact of SQ-LNS supplementation on
maternal PPD is consistent with what was found in the iLiNS-
Malawi trial (Stewart et al. 2016) which used the same study
design as our study. It is possible that the formulation of SQ-
LNS used in these trials (which included 0.59 g alpha-
linolenic acid (ALA) and 4.59 g linoleic acid) did not contain
enough essential fatty acids (EFA) to influence depression, or
there was insufficient conversion of the pre-cursor ALA to the
longer chain fatty acids eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA). A recent meta-analysis of de-
pression trials showed that EPA/DHA supplements containing
much higher doses (>60%) of EPA (ranging from 0.2 to 2.2 g,
in excess of DHA) were more effective in treating depression
(Sublette et al. 2011) than supplements containing lower doses
Fig. 1 Study profile. The IFA
group received 60 mg iron plus
400 mg folic acid. The MMN
group received 1–2
Recommended Dietary
Allowances of 18 vitamins and
minerals (including 20 mg iron).
The LNS group received SQ-LNS
with the same micronutrients as
the MMN group, plus another
four minerals (Ca, P, K and Mg),
as well as macronutrients. All
three supplements were intended
for daily consumption. IFA iron
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(<60%) of EPA. Thus, increasing the ALA dose in future SQ-
LNS supplements to levels higher thanwe used in our study or
including EPA/DHA (with higher EPA dose) may be more
likely to influence depression.
Alternatively, it is possible that women in the study area
regularly consumed fish with high EFA content and so had
adequate EFA status at baseline, making it difficult to ob-
serve an effect of SQ-LNS supplementation on depression.
Data from the Food and Agriculture Organization balance
sheets support the possibility of high fish consumption in
Ghana (Michaelsen et al. 2011). Data previously reported
from our study also show the EFA status of women at
baseline to be within normal levels (Oaks et al. 2017).
Additionally, it is also possible that depressive symptoms
were not common in our sample at baseline, before supple-
mentation, which would also make it difficult to detect any
effect of supplementation. We did not collect data on base-
line depression status, so we cannot evaluate this possibil-
ity. Lastly, it is possible that other causes of depression
were more influential in our population than nutrition-
related factors. A number of non-dietary factors including
marital status and relationship, social support, childcare
stress, infant temperament, socioeconomic status and un-
planned pregnancy have been reported to be strong predic-
tors of postpartum depression (Beck 2001).
Results of our pre-specified tests for interactions sug-
gested that season when depression data were collected,
child sex and housing index modified the effect of the
Table 1 Composition and
formulation of supplements used
in the study
Nutrient Chemical form used in supplement formulation IFA MMN SQ-LNSa
Ration (g/day) 1 tablet 1 tablet 20
Total energy (kcal) 0 118
Protein (g) 0 2.6
Fat (g) 0 10
Linoleic acid (g) 0 4.59
α-Linolenic acid (g) 0 0.59
Vitamin A (μg RE) Retinyl acetate 800 800
Vitamin C (mg) L-ascorbic acid 100 100
Vitamin B1(mg) Thiamin hydrochloride 2.8 2.8
Vitamin B2 (mg) Riboflavin 2.8 2.8
Niacin (mg) Niacinamide 36 36
Folic acid (μg) Pteroyl monoglutamic acid 400 400 400
Pantothenic acid (mg) Calcium pantothenate 7 7
Vitamin B6 (mg) Pyridoxine hydrochloride 3.8 3.8
Vitamin B12 (μg) Cyanocobalamin (0.1%) 5.2 5.2
Vitamin D (IU) Cholecalciferol (D3) 400 400
Vitamin E (mg) DL-alpha-tocopherol acetate 20 20
Vitamin K (μg) Phylloquinone 5% 45 45
Iron (mg) Encapsulated ferrous sulphate 60 20 20
Zinc (mg) Zinc sulphate 30 30
Copper (mg) Encapsulated copper sulphate 4 4
Calcium (mg) Tricalcium phosphate 0 280
Phosphorus (mg) Tricalcium phosphate 0 190
Dipotassium phosphate
Potassium (mg) Potassium chloride 0 200
Dipotassium phosphate
Magnesium (mg) Magnesium citrate 0 65
Selenium (μg) Sodium selenite 1.5% 130 130
Iodine (μg) Potassium iodate 250 250
Manganese (mg) Manganese sulphate 2.6 2.6
Information from table previously published from Adu-Afarwuah et al. (2015) and Arimond et al. (2013)
IFA iron and folic acid capsule, MMN multiple micronutrient supplement capsule, SQ-LNS small-quantity lipid-
based nutrient supplement for pregnant and lactating women
aNutrient concentrations include contributions from the ingredients as well as from the multiple micronutrient
premix
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intervention. Among women interviewed during the dry
season, those in the LNS group had significantly lower
EPDS scores compared to those in the MMN group. It
is possible that SQ-LNS mitigated the impact of the dry
season on women’s depressive symptoms. The dry season
is usually the post-harvest season, the period before the
next planting season when food is sometimes scarce and
food insecurity may be common. Similarly, among
women who delivered female infants, those in the LNS
group tended to have lower depression scores compared
to those in the MMN group. Studies in India (Patel et al.
2002), Nigeria (Adewuya et al. 2005) and Turkey (Ekuklu
et al. 2004) have reported PPD to be more common
among mothers of female babies, and this has usually
been explained by the societal preference for male com-
pared to female children. Nonetheless, we cannot
Table 2 Baseline characteristics
of women by intervention group,
among those with data on
depression at 6 months
postpartum
Variable LNS (n = 382)a IFA (n = 385)a MMN (n = 382)a
Age (years) 27.1 ± 5.5 26.6 ± 5.5 26.8 ± 5.3
Height (cm) 159.1 ± 5.4 159 ± 5.7 159 ± 6.1
BMI (kg/m2) 25.2 ± 4.7 24.7 ± 4.5 24.8 ± 4.4
Years of formal education (years) 7.6 ± 3.9 7.8 ± 3.5 7.5 ± 3.6
Married or cohabiting 352 (92.1) 357 (92.7) 361 (94.5)
Primiparous 122 (31.9) 133 (34.5) 123 (32.2)
Anaemia (g/L)b 148 (38.7) 164 (42.6) 154 (40.3)
Gestational age at enrolment (weeks) 16.2 ± 3.3 16.0 ± 3.2 16.3 ± 3.2
Season when depression data collected = dry season 185 (48.4) 192 (49.9) 200 (52.4)
Child sex = male 190 (49.9) 175 (45.6) 191 (50.0)
Household asset index −0.06 ± 1.01 0.03 ± 1.02 0.07 ± 0.94
Housing index −0.02 ± 1.00 0.02 ± 1.02 −0.02 ± 1.02
Household food insecurity index 2.4 ± 4.0 2.6 ± 4.4 2.7 ± 4.4
LNS group: women were intended to receive 20 g SQ-LNS with same micronutrients as the MMN group, plus
another four minerals (Ca, P, K and Mg) as well as macronutrients during pregnancy and the first 6 months
postpartum; IFA group: women were intended to receive 60 mg iron plus 400 μg folic acid during pregnancy and
a calcium placebo during the first 6 months postpartum;MMNgroup: womenwere intended to receive 1–2 RDAs
of 18 vitamins and minerals (including 20 mg iron) during pregnancy and the first 6 months postpartum. All three
supplements were intended for daily consumption
a Values are mean ± SD or n (%)
bAnaemia based on WHO cut off of 110 g/L
Table 3 EPDS scores at 6 months postpartum by intervention group (unadjusted and adjusted analysis)





























4.0 (1.0–8.0) 4.0 (1.0–8.0) 5.0 (2.0–9.0) 0.13 0.03 (−0.17, 0.24) 0.92 0.17 (−0.04, 0.37) 0.14 −0.13 (−0.34, 0.07) 0.28
EPDS score
(adjusted)c
0.17 0.02 (−0.18, 0.22) 0.97 0.15 (−0.05, 0.35) 0.19 −0.13 (−0.33, 0.07) 0.29
LNS group: women were intended to receive 20 g SQ-LNS with same micronutrients as the MMN group, plus another four minerals (Ca, P, K andMg)
as well as macronutrients during pregnancy and the first 6 months postpartum; IFA group: women were intended to receive 60 mg iron plus 400 μg folic
acid during pregnancy and a calcium placebo during the first 6 months postpartum; MMN group: women were intended to receive 1–2 RDAs of 18
vitamins and minerals (including 20 mg iron) during pregnancy and the first 6 months postpartum. All three supplements were intended for daily
consumption
EPDS Edinburgh Postnatal Depression Scale
aMedian (25–75 percentile)
b The EPDS scores were square-root transformed for the analysis. Reported P values are for the transformed scores
c Adjusted for household food insecurity index
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completely rule out the possibility that the interaction re-
sults may be spurious.
Strengths of our study include the randomized design of the
trial, blinding of study participants to IFA/MMN treatment,
large sample size, long follow-up and low drop-out rate.
There were a few limitations that warrant mention. First, we
did not have data on the depression symptoms in our sample at
baseline, before supplementation. Second, due to the differ-
ences between the IFA/MMN capsules and SQ-LNS sachets,
we were unable to blind study participants and field workers
to IFA/MMN vs SQ-LNS treatment. However, field workers
were blinded to the study hypothesis and taken through regu-
lar refresher training, and data analysts were fully blinded to
group assignments until analyses were completed. Thirdly, in
spite of our effort to ensure good quality data by organizing
regular refresher training for our data collectors, the possibility
of measurement error still remains, which could also have
influenced our results and estimate of depression in the
Ghanaian population. Lastly, in this study, we measured de-
pression using a screening tool instead of a diagnostic inter-
view. We acknowledge that using a diagnostic interview
would have increased our confidence in our results, but we
were limited by resource constraints. It is worth noting, how-
ever, that the EPDS screening tool has been widely validated
and used in different low-income populations including
Ghana (Nhiwatiwa et al. 1998; Okronipa et al. 2012; Stewart
et al. 2016; Uwakwe 2003) to measure symptoms of depres-
sion. We therefore believe that the study’s weaknesses do not
bias the finding of no association of maternal SQ-LNS con-
sumption during pregnancy and lactation with depressive
symptoms at 6 months postpartum.
In conclusion, this study did not provide evidence to sup-
port the hypothesis that supplementing maternal diet with SQ-
LNS will improve maternal depression scores at 6 months
postpartum. However, the significant interaction with season
warrants further study.
Table 4 EPDS ≥12 at 6 months postpartum by intervention group (unadjusted and adjusted analysis)






















50 (13.1) 43 (11.2) 56 (14.7) 0.35 0.83 (0.50–1.40) 0.69 1.14 (0.70–1.87) 0.80 0.73 (0.44–1.22) 0.32
EPDS ≥12
(adjusted)a
0.32 0.79 (0.47–1.35) 0.55 1.09 (0.67–1.81) 0.89 0.72 (0.43–1.21) 0.30
LNS group: women were intended to receive 20 g SQ-LNS with same micronutrients as the MMN group, plus another four minerals (Ca, P, K andMg)
as well as macronutrients during pregnancy and the first 6 months postpartum; IFA group: women were intended to receive 60 mg iron plus 400 μg folic
acid during pregnancy and a calcium placebo during the first 6 months postpartum; MMN group: women were intended to receive 1–2 RDAs of 18
vitamins and minerals (including 20 mg iron) during pregnancy and the first 6 months postpartum. All three supplements were intended for daily
consumption
EPDS Edinburgh Postnatal Depression Scale
a Adjusted for maternal years of education and household food insecurity index
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